The Story of Infunenza Antivirals: Part 6

The BMJ 12 December 2009 issue

Together with our updated review (minus the eight unpublished trials included in the Kaiser meta-analysis), the BMJ published several linked articles in one issue, almost constituting a monograph.

The editor-in-chief, Godlee, asked why we could not have access to data for a drug in which the public purse had invested billions. Deborah Cohen, who had led …